http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9911178-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
filingDate 1999-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c003d994ad83a762dbcd17ab87ccbd42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f02eadb7dd685b522cf7ff0db7298fa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_033f175937882d6b6bacfb34695a95bb
publicationDate 2001-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9911178-A
titleOfInvention Derivatives of 3- (2-oxo- [1,3 '] bipyrrolidinyl-3-ylidenomethyl) -cefems
abstract Invention Patent: <B> "DERIVATIVES OF 3- (2-OXO- [1,3 '] BIPIRROLIDINYL-3-ILIDENOMETHYL) -CEFEMS" <D>. The present invention relates to new compounds of the formula (I) in which R ^ 1 ^ is hydrogen, C ~ 1-6 ~ alkyl, optionally substituted by fluorine, or C ~ 3-6 ~ cycloalkyl; R ^ 2 ^ is hydrogen or a group selected from -CH ~ 2 ~ C (= CHR) -COOR, -CH ~ 2 ~ OCOR, -CH (R) OCOR, -CH (R) OCOOR, -CH (OCOR) OCOR, -CR ~ 2 ~ COCH ~ 2 ~ OCOR and (II); R ^ 3 ^ is hydrogen or a group selected from -CH ~ 2 ~ C (= CH ~ 2 ~) -COOR, -COOCH ~ 2 ~ C (= CHR) -COOR, -COOCH ~ 2 ~ OCOR, -COOCH (R ) OCOR, -COOCH (R) OCOOR, -COOCH (OCOR) OCOR, -COOCH ~ 2 ~ COCH ~ 2 ~ OCOR, and (III); with the proviso that one of R ^ 2 ^ and R ^ 3 ^ is hydrogen and the other of R ^ 2 ^ and R ^ 3 ^ is different from hydrogen, R is hydrogen or C ~ 1-6 ~ alkyl; R ^ 4 ^ is hydrogen or hydroxy, R ^ 5 ^ is hydrogen or <SYM> -hydroxyalkyl; and X is CH or N, as well as to pharmaceutically acceptable salts of said compounds and hydrates of said compounds and their salts, and to the use of compounds of formula (I) and pharmaceutically acceptable salts of said compounds and hydrates of said compounds and salts for the manufacture of pharmaceutical preparations containing such compounds.
priorityDate 1998-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 25.